The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer

被引:4
|
作者
Prayudi, Pande Kadek Aditya [1 ,2 ]
Winata, I. Gde Sastra [1 ,2 ]
Mahendra, Nyoman Bayu [1 ,2 ]
Budiana, I. Nyoman Gede [1 ,2 ]
Saspriyana, Kade Yudi [1 ,2 ]
Suwiyoga, Ketut [1 ,2 ]
机构
[1] Prof Dr I GNG Ngoerah Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Denpasar 80113, Bali, Indonesia
[2] Udayana Univ, Fac Med, Denpasar 80113, Bali, Indonesia
来源
关键词
ovarian cancer; epithelial-to-mesenchymal transition; cellular reprogramming; PROMOTES VASCULOGENIC MIMICRY; HEDGEHOG SIGNALING PATHWAY; E-CADHERIN; CELL-MIGRATION; STEM-CELLS; TRANSCRIPTION FACTORS; CISPLATIN-RESISTANCE; POOR SURVIVAL; LNCRNA-ATB; EMT;
D O I
10.31083/j.ceog5012272
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To understand the basic mechanism and dynamic regulation that underlies the epithelial-to-mesenchymal transition (EMT) in ovarian cancer (OC) cells. Mechanism: A literature review using evidences from several data bases (i.e., PubMed, EMBASE, Web of Science, Medline, Cochrane, Science Direct, and Google Scholar) were conducted to describe the basic mechanism and dynamic regulation of EMT in OC cells. Finding in Brief: EMT is a complex epigenetic reprogramming orchestrated by specific transcription factors (TFs) and multiple upstream activators and regulators, such as transforming growth factor-0 (TGF-0), Wnt, Hedgehog, and Hippo signaling pathways. The net result of this cellular reprogramming is the acquisition of mesenchymal phenotypes with increased invasive and metastatic potential, stemness properties and chemoresistance. Recent studies have demonstrated that EMT activation is the result of dynamic and reciprocal interplay between OC cells and their tumor microenvironment (TME). Cellular or non-cellular component of TME, external factors related to TME such as hypoxia, oxidative stress, mechanical forces, as well as exposure to chemotherapy, all play significant role to EMT induction. Current understanding behind the mechanism of EMT induction in cancer cells have proposed the idea that EMT is not merely a binary process involving a complete conversion from epithelial to mesenchymal state, but rather a dynamic process that encompasses a range of hybrid states, a phenotype that has been referred to as "partial EMT". Cells with partial EMT have been known to be more apoptosis-resistant and have more tumor-initiating potential as compared to those with complete EMT. Conclusions: Understanding the complex regulatory network that underlies EMT in OC cells is crucial in order to gain insight in developing novel and effective treatment strategies for OC.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] THE EFFICACY OF EPITHELIAL-MESENCHYMAL TRANSITION (EMT) SCORING ASSAY IN EPITHELIAL OVARIAN CANCER (EOC)
    Huang, R. Y. J.
    Ye, J.
    Tan, T. Z.
    Lim, D.
    Low, J.
    Choolani, M.
    Tan, D. S. P.
    Thiery, J. P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 163 - 163
  • [32] Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
    Marchini, Sergio
    Fruscio, Robert
    Clivio, Luca
    Beltrame, Luca
    Porcu, Luca
    Nerini, Ilaria Fuso
    Cavalieri, Duccio
    Chiorino, Giovanna
    Cattoretti, Giorgio
    Mangioni, Costantino
    Milani, Rodolfo
    Torri, Valter
    Romualdi, Chiara
    Zambelli, Alberto
    Romano, Michela
    Signorelli, Mauro
    di Giandomenico, Silvana
    D'Incalci, Maurizio
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (02) : 520 - 530
  • [33] Regulation of epithelial to mesenchymal transition by BRCA1 in breast cancer
    Sengodan, Satheesh Kumar
    Sreelatha, K. H.
    Nadhan, Revathy
    Srinivas, Priya
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 123 : 74 - 82
  • [34] Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
    Luu, Tuan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
    Brown, Taylor C.
    Sankpal, Narendra, V
    Gillanders, William E.
    BIOMOLECULES, 2021, 11 (07)
  • [36] BETA-ADRENERGIC ACTIVATION OF EPITHELIAL-MESENCHYMAL TRANSITION IN OVARIAN CANCER
    Lutgendorf, S. K.
    Thaker, P. H.
    Slavich, G. M.
    Goodheart, M. J.
    Dahmoush, L.
    Lubaroff, D. M.
    Penedo, F. J.
    Sood, A. K.
    Cole, S. W.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 : S121 - S122
  • [37] Isoliquiritigenin Inhibits Ovarian Cancer Metastasis by Reversing Epithelial-to-Mesenchymal Transition
    Chen, Chen
    Huang, Shuang
    Chen, Chang-Liang
    Su, Sing-Bing
    Fang, Dong-Dong
    MOLECULES, 2019, 24 (20):
  • [38] The mechanism between epithelial mesenchymal transition in breast cancer and hypoxia microenvironment
    Gao, Tong
    Li, Jia-zhi
    Lu, Ying
    Zhang, Chun-ying
    Li, Qing
    Mao, Jun
    Li, Lian-hong
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 80 : 393 - 405
  • [39] Sauchinone inhibits the growth and epithelial-mesenchymal transition of ovarian cancer cells
    Li, Na
    Cui, Yujie
    Wang, Xian
    Li, Yucheng
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2024, 45 (06) : 190 - 196
  • [40] The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
    Lo, U-Ging
    Lee, Cheng-Fan
    Lee, Ming-Shyue
    Hsieh, Jer-Tsong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)